BenzingaOctober 20, 2026 at 2:53 AM NY7 Days Ago
B of A Securities Maintains Buy on Gilead Sciences, Raises Price Target to $172
B of A Securities analyst Tim Anderson maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $168 to $172.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
